Skip to main content
Healthcare

STAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more

STAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more

Feed excerpt — reported by STAT News

The FDA created a new internal safety body in its biologics ​center, formalizing independent oversight of ‌vaccines and gene therapies

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.